Enterotoxin adjuvants have direct effects on T cells and antigen- presenting cells that result in either interleukin-4-dependent or - independent immune responses

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 180-190

  Yamamoto, Masafumi ^a,b,e   Kiyono, Hiroshi ^b,e   Kweon, Mi Na ^b   Yamamoto, Shingo ^e   Fujihashi, Kohtaro ^e   Kurazono, Hisao ^e   Imaoka, Koichi ^e   Bluethmann, Horst ^f   Takahashi, Ichiro ^b   Takeda, Yoshifumi ^c   Azuma, Miyuki ^d   McGhee, Jerry R ^e  

^a NIHON UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^f F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; IMMUNOGLOBULIN A; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CYTOKINE PRODUCTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD86; BACTERIAL TOXINS; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; IMMUNITY, MUCOSAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 0033929615     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315694     Document Type: Article

References (47)

1. 1. Clements JD, Hartzog NM, Lyon FL. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988; 6:269-77.
2. 2. Holmgren J, Lycke N, Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 1993; 11: 1179-84.
3. 3. Yamamoto S, Kiyono H, Yamamoto M, et al. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci USA 1997; 94:5267-72.
4. 4. Marinaro M, Staats HF, Hiroi T, et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol 1995; 155:4621-9.
5. 5. Xu-Amano J, Kiyono H, Jackson RJ, et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993; 178:1309-20.
6. 6. Munoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 1990; 172: 95-103.
7. 7. Takahashi I, Kiyono H, Marinaro M, et al. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis 1996; 173:627-35.
8. 8. LeGros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990; 172:921-9.
9. 9. Sad S, Mosmann TR. Single IL-2-secreting precursor CD4 T cell can develop into Th1 or Th2 cytokine secretion phenotype. J Immunol 1994; 153: 3514-22.
10. 10. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145:3796-806.
11. 11. Kopf M, LeGros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362:245-8.
12. + Th2 cells producing IL-6 and IL-10 are associated with mucosal IgA responses. Infect Immun 1996; 64:1516-25.
13. 13. Vajdy M, Kosco-Vilbois MH, Kopf M, Kohler G, Lyke N. Impaired mucosal immune responses in interleukin-4-targeted mice. J Exp Med 1995; 181: 41-53.
14. 14. Beagley KW, Eldridge JH, Kiyono H, et al. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol 1988; 141:2035-42.
15. 15. Beagley K, Eldridge JH, Lee F, et al. Interleukins and IgA synthesis. Human and murine IL-6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989; 169:2133-48.
16. 16. Briere F, Bridon JM, Chevet D, et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994; 94:97-104.
17. 17. Coffman RL, Shrader B, Carty J, Mosmann TR, Bond MW. A mouse T cell product that preferentially enhances IgA production. I. Biologic characterization. J Immunol 1987; 139:3685-90.
18. 18. Kunimoto DY, Nordan RP, Strober W. IL-6 is a potent co-factor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J Immunol 1989; 143:2230-5.
19. 19. VanCott JL, Staats HF, Pascual DW, et al. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol 1996; 156:1504-14.
20. 20. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233-58.
21. 21. Ågren LC, Ekman L, Lowenadler B, Lycke NY. Genetically engineered nontoxic vaccine adjuvant that combine B cell targeting with immunomodulation by cholera toxin A1 subunit. J Immunol 1997; 158:3936-46.
22. 22. Cong Y, Weaver CT, Elson CO. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. J Immunol 1997; 159:5301-8.
23. 23. Yamamoto M, Kiyono H, Yamamoto S, et al. Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant. J Immunol 1999; 162:7015-21.
24. 24. Uesaka Y, Otsuka Y, Lin Z, et al. Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microb Pathog 1994; 16:71-6.
25. 25. Jackson RJ, Fujihashi K, Xu-Amano J, Kiyono H, McGhee JR. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect Immun 1993; 61:4272-9.
26. 26. Wu JY, Riggin CH, Seals JR, Murphy CI, Newman MJ. In vitro measurement of antigen-specific cell-mediated immune responses using recombinant HIV-1 proteins absorbed to latex microspheres. J Immunol Methods 1991; 143:1-9.
27. 27. Hiroi T, Fujihashi K, McGhee JR, Kiyono H. Polarized Th2 cytokine expression by both mucosal γδ and αβ T cells. Eur J Immunol 1995; 25: 2743-51.
28. 28. Lu W, Han DS, Yuan J, Andrieu JM. Multi-target PCR analysis by capillary electrophoresis and laser-induced fluorescence. Nature 1994; 368:269-71.
29. 29. Yamamoto M, Kawabata K, Fujihashi K, et al. Absence of exogenous IL-4-induced apoptosis of gingival macrophage may contribute to chronic inflammation in periodontal diseases. Am J Pathol 1996; 148:331-9.
30. 30. Sakaguchi M, Inouye S, Miyazawa H, Tamura S. Measurement of antigen-specific mouse IgE by a fluorometric reverse (IgE-capture) ELISA. J Immunol Methods 1989; 116:181-7.
31. 31. Jackson RJ, Fujihashi K, Kiyono H, McGhee JR. Luminometry: a novel bioluminescent immunoassay enhances the quantitation of mucosal and systemic antibody responses. J Immunol Methods 1996; 190:189-97.
32. + T cells that secrete IFN-γ and IL-5. J Immunol 1990; 145:68-77.
33. 33. Griffiths SL, Finkelstein RA, Critchley RR. Characterization of the receptor for cholera toxin and Escherichia coli heat-labile enterotoxin in rabbit brush borders. Biochem J 1986; 238:313-22.
34. 34. Holmgren J, Fredman P, Lindblad M, Svennerholm AM, Svennerholm L. Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun 1982; 38:424-33.
35. 35. Holmgren J, Lindblad M, Fredman P, Svennerholm L, Myrvold H. Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology 1985; 89:27-35.
36. 36. Renshaw BR, Fanslow WCI, Armitage RJ, et al. Humoral immune responses in CD40 ligand deficient mice. J Exp Med 1994; 180:1889-900.
37. 37. Xu J, Foy TM, Laman JD, et al. Mice deficient for the CD40 ligand. Immunity 1994; 1:423-31.
38. 38. Spangler BD. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 1992; 56:622-47.
39. + T cells and induce similar patterns of cytokine secretion in vitro. Int Immunol 1995; 7:891-904.
40. 40. Lanier LL, O'Fallon S, Somoza C, et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995; 154:97-105.
41. 41. Natesan M, Razi-Wolf Z, Reiser H. Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. J Immunol 1996; 156:2783-91.
42. 42. Kuchroo VK, Das MP, Brown JA. et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80:707-18.
43. 43. Freeman GJ, Boussiotis VA, Anumanthan A, et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995; 2:523-32.
44. 44. Lenschow DJ, Ho SC, Sattar H, et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995; 181:1145-55.
45. + T cells for helper activity. Int Immunol 1993; 5:1473-81.
46. + T cells produce IFN-γ and IL-5. J Immunol 1991; 147:3736-44.
47. 47. Yamamoto M, Fujihashi K, Beagley KW, McGhee JR, Kiyono H. Cytokine synthesis by intestinal intraepithelial lymphocytes. Both γ/δ T cell receptor positive and α/β T cell receptor-positive T cells in the G1 phase of cell cycle produce IFN-γ and IL-5. J Immunol 1993; 150:106-14.